Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology ...

Deficiency of 25-hydroxyvitamin D at age 3 years is associated with more than double the risk for eosinophilic asthma in ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

A new study from Huashan Hospital, Shanghai, provided strong evidence supporting the efficacy and safety of abrocitinib for ...

CITRYLL DEMONSTRATES A BROADER THERAPEUTIC POTENTIAL FOR CIT-013 IN THE TREATMENT OF INFLAMMATORY DISORDERS Breakthrough ...

Respiratory nurse lead Carol Stonham outlines what nurses in primary care need to know about changes in the diagnosis and ...

A New England woman who thought she was merely jetlagged after vacationing overseas and later felt her feet burning learned from doctors that she had contracted a brain worm infection, a case study ...

A new study published in Respiratory Medicine has found that diaphragm dysfunction is more common in asthma patients and is ...

An expert review provides best practice advice on diagnostic considerations of immune-mediated disorders that should be ...